Synoptech

Synoptech appears to be a legitimate early-stage startup (linked to Treefrog Accelerator) in the high-potential biometric tracking market. However, the submission is critically flawed: it contains demonstrably false traction claims ('most people have used my product'), confuses market cap with revenue, and lists a team size (125) that contradicts its seed-stage financial profile. While the underlying technology and market timing are promising, the poor response quality and lack of verifiable evidence significantly penalize the score, placing it in the 'minimal to early traction' range.